Literature DB >> 10813282

KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.

H Nakajima1, M Harigai, M Hara, M Hakoda, H Tokuda, F Sakai, N Kamatani, S Kashiwazaki.   

Abstract

OBJECTIVE: To investigate the diagnostic value of the serum concentrations of KL-6, a mucinous glycoprotein expressed on type II pneumocytes, for interstitial pneumonia (IP) in various collagen diseases.
METHODS: Serum KL-6 levels were measured by ELISA.
RESULTS: The mean values and the positive rates of serum KL-6 levels for patients with rheumatoid arthritis, systemic sclerosis, or polymyositis/dermatomyositis with IP were significantly higher than those without IP. Sensitivity, specificity, positive and negative predictive values of serum KL-6 level for IP associated with collagen diseases were 60.7, 98.9, 97.4, and 77.1%, respectively. The mean serum KL-6 level of patients with active IP was significantly (p = 0.0001) higher than that of patients with inactive IP. Serum KL-6 levels increased with the deterioration of IP, while the successful treatment of IP resulted in a significant decrease of these levels.
CONCLUSION: Serum KL-6 concentration levels are a useful marker for diagnosis and evaluation of the disease activity of IP associated with collagen diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10813282

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Serum KL-6 levels in patients with pulmonary complications after allogeneic bone marrow transplantation.

Authors:  T Ashida; M Higashishiba; Y Sumimoto; T Sano; H Miyazato; T Shimada; J Miyatake; K Kawanishi; Y Tatsumi; A Kanamaru
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

2.  Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.

Authors:  Kunihiko Miyazaki; Koichi Kurishima; Katsunori Kagohashi; Mio Kawaguchi; Hiroichi Ishikawa; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis.

Authors:  Nobuyoshi Kitaichi; Toshihide Ariga; Satoru Kase; Kauzhiko Yoshida; Kenichi Namba; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-23       Impact factor: 3.117

4.  Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody.

Authors:  Kentaro Isoda; Takuya Kotani; Tohru Takeuchi; Takao Kiboshi; Kenichiro Hata; Takaaki Ishida; Kenichiro Otani; Takao Kamimori; Hiroshi Fujiwara; Takeshi Shoda; Shigeki Makino
Journal:  Rheumatol Int       Date:  2017-04-27       Impact factor: 2.631

5.  High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia.

Authors:  H Ishii; H Mukae; J Kadota; H Kaida; T Nagata; K Abe; S Matsukura; S Kohno
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

6.  The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient.

Authors:  Hiroki Kobayashi; Yusuke Yoshida; Tomoki Komoshita; Harumichi Suma; Yohei Hosokawa; Yoshikazu Hirose; Tomohiro Sugimoto; Sho Mokuda; Shintaro Hirata; Eiji Sugiyama
Journal:  Intern Med       Date:  2021-11-13       Impact factor: 1.282

7.  Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis.

Authors:  Atsushi Tanaka; Hiroshi Tsukamoto; Hiroki Mitoma; Chikako Kiyohara; Naoyasu Ueda; Masahiro Ayano; Shun-ichiro Ohta; Yasutaka Kimoto; Mitsuteru Akahoshi; Yojiro Arinobu; Hiroaki Niiro; Yoshifumi Tada; Takahiko Horiuchi; Koichi Akashi
Journal:  Arthritis Res Ther       Date:  2015-02-10       Impact factor: 5.156

8.  Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study.

Authors:  Kakuhiro Yamaguchi; Hiroshi Iwamoto; Shinjiro Sakamoto; Yasushi Horimasu; Takeshi Masuda; Shintaro Miyamoto; Taku Nakashima; Shinichiro Ohshimo; Kazunori Fujitaka; Hironobu Hamada; Nobuoki Kohno; Noboru Hattori
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

9.  Serum Metabolomic Profiles of Rheumatoid Arthritis Patients With Acute-Onset Diffuse Interstitial Lung Disease.

Authors:  Hiroshi Furukawa; Shomi Oka; Kota Shimada; Atsushi Hashimoto; Akiko Komiya; Toshihiro Matsui; Naoshi Fukui; Shigeto Tohma
Journal:  Biomark Insights       Date:  2019-08-22

10.  Serum heat shock protein 47 levels are elevated in acute interstitial pneumonia.

Authors:  Tomoyuki Kakugawa; Shin-Ichi Yokota; Yuji Ishimatsu; Tomayoshi Hayashi; Shota Nakashima; Shintaro Hara; Noriho Sakamoto; Hiroshi Kubota; Mariko Mine; Yasuhiro Matsuoka; Hiroshi Mukae; Kazuhiro Nagata; Shigeru Kohno
Journal:  BMC Pulm Med       Date:  2014-03-21       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.